BUD23 and hepatocellular carcinoma: The upregulation of METTL1 and WBSCR22 in glioma is also linked with the oncogenic process21, while METTL1 can inhibit PTEN signaling in hepatocellular carcinoma cells, thus enhancing their proliferative and migratory activity24.